FDC's record shows a profitable, dividend-paying company with a clean balance sheet and no pledged shares, but the profits have not consistently turned into cash, and the board and audit notes carry recurring patterns that a retail investor should understand before relying on the headline numbers.
Key findings
- Operating cash flow covers only 68% of EBITDA over ten years, while ₹510 crore went to buybacks
Major- Over the ten-year history, cumulative operating cash flow was ₹1,775 crore against operating profit of ₹2,599 crore, a ratio of 0.68x. In four of the last five years, cash flow fell short of profit, with CFO/PAT at 0.71x in FY2026 and 0.72x in FY2024. The company funded four buybacks totalling ₹510 crore from its General reserve, and declared interim dividends of ₹5 per share in February 2026 and for FY2024-25. - Reported profits are repeatedly shaped by accounting choices, with impacts never quantified
Major- In FY2025-26, FDC booked a ₹20.79 crore exceptional charge for the new Labour Codes, then reversed ₹8.93 crore of it after a leave-policy revision, cutting the year-end liability to ₹11.3 crore from ₹22.79 crore. In every year from FY2019-20 through FY2024-25, management reassessed asset useful lives and stated the impact was "not material for the year" without quantifying it. A ₹3.58 crore deferred-tax remeasurement gain lifted FY2019-20 profit. - Repeated loans to a South African subsidiary were impaired for years, then converted to equity
Major- Parent loans to Fair Deal Corporation Pharmaceuticals SA rose from ₹3.65 crore in FY2020 to ₹21.15 crore in FY2023, with impairments booked on the loans and receivables in most years, including ₹15.86 crore in FY2023. In FY2024, FDC converted a ₹21.51 crore loan into equity, making the subsidiary wholly owned. Shareholders had approved the loans at 7.5% and 8.5% simple interest for three years. - A five-member family bloc dominates the board, and promoter votes carried resolutions institutions opposed
Major- As of March 31, 2026, five Chandavarkar family members sat on the 10-member board, including the Managing Director aged 87 and an Executive Director aged 84, both re-appointed for five-year terms. In the July 2024 postal ballot, public institutions voted 34.5% against an Independent Director's re-appointment while promoters voted 100% in favour. Promoter and promoter-group shareholding stood at 69.66% with zero pledge. - The "debt-free" claim sits alongside a sales-tax deferral liability to the Maharashtra government
Minor- FDC's standalone and consolidated statements call the company debt-free while separately disclosing interest-free sales-tax deferral incentives from the Government of Maharashtra, repayable in instalments over 9-13 years. The same pairing appears in every annual report from FY2019-20 through FY2024-25. Repayments were tiny, at ₹13.58 lakh in FY2022 and ₹7.59 lakh in FY2024. - A stable ₹22.5 crore litigation provision sits against fresh tax demands of over ₹23 crore in 2025
Minor- FDC has carried a ₹22.5 crore provision for probable litigation outflows since FY2020. In 2025 alone, GST and customs authorities issued three demands totalling over ₹23 crore in tax, interest and penalties, including a ₹15.61 crore GST demand in December 2025. The company says it will appeal or seek legal remedy with no material financial impact. - Revenue recognition is flagged as a fraud-risk audit matter every year, but receivables stay clean
Minor- The auditor has named revenue recognition a Key Audit Matter in every report from FY2019-20 through FY2025-26, citing the presumed fraud risk of overstated revenue. No single customer has reached 10% of revenue in any of those years, and no unbilled receivables were reported. US sales grew 165% to ₹70.6 crore in FY2025-26, but profit share from the US fell from ₹37.3 crore to ₹23.3 crore. - The only goodwill impairment was a one-time FY2021 charge, with subsidiary provisions later written back
Minor- FDC recorded a goodwill impairment on its South African acquisition in FY2020-21, and has recorded no impairment losses since. The standalone cash flow shows a 2.37 crore write-back of subsidiary impairment provision in FY2024, against a 6.14 crore charge in FY2022.
What to watch
- GST and customs appeals. Three demands totalling over ₹23 crore were issued between January 2025 and December 2025; the outcomes of FDC's appeals are pending.
- 86th AGM, September 24, 2026. Re-appointment of Mr. Ashok Anand Chandavarkar, Executive Director, who retires by rotation.
- Chairman and MD roles combined. Mr. Mohan A. Chandavarkar was re-designated Chairman & Managing Director effective April 1, 2026, ending the separation of roles in place since April 1, 2019.
- Labour Code rules. Finalisation of Central and State rules could trigger further adjustments to the ₹20.79 crore exceptional obligation recognised in FY2025-26.
Bottom line: This is a profitable, dividend-paying company with a genuinely clean balance sheet, no pledge, and no customer concentration. The character of the risk is cash conversion and governance: profits have repeatedly outrun operating cash, shareholder returns have been funded from reserves, and a family bloc controls both the board and the voting outcomes. Read the cash flow statement before the income statement, and watch the appeals and the AGM.